Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Dose-Response Study of DE-089 Ophthalmic Solution in Patients With Dry Eye -Late Phase II Confirmatory Study-

Dose response related to efficacy and safety of DE-089 ophthalmic solution are examined in patients with dry eye, using a multicenter, randomized, double-blind, parallel group comparison study, and the optimal concentration is determined.

Inclusion Criteria:

• Those who show:

  • Keratoconjunctival disorder confirmed with vital dye staining
  • Abnormal Schirmer score results

Exclusion Criteria:

• Eye disease that needs therapy other than that for dry eye
• Those who need to wear contact lenses during the clinical study